hydralazine and 20-hydroxy-5,8,11,14-eicosatetraenoic acid

hydralazine has been researched along with 20-hydroxy-5,8,11,14-eicosatetraenoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capdevila, JH; Falck, JR; Gangadhariah, MH; Garcia, V; Hayward, SW; Imig, JD; Love, HD; Luther, JM; Manthati, VL; Paueksakon, P; Pozzi, A; Schwartzman, ML; Zent, R; Zhang, MZ1

Other Studies

1 other study(ies) available for hydralazine and 20-hydroxy-5,8,11,14-eicosatetraenoic acid

ArticleYear
Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy.
    Journal of the American Society of Nephrology : JASN, 2015, Volume: 26, Issue:3

    Topics: Animals; Collagen; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Diabetic Nephropathies; Glomerular Basement Membrane; Hydralazine; Hydrochlorothiazide; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Mice, Knockout; Orchiectomy; Renin-Angiotensin System; Reserpine; Sodium

2015